Menstrual cycle characteristics and incidence of premenopausal breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 6, 2005, Pages 1509-1513

  Terry, Kathryn L ^a,b   Willett, Walter C ^a,b   Rich Edwards, Janet W ^a,b,c   Hunter, David J ^a,b   Michels, Karin B ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD PILGRIM HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANOVULATION; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; ONSET AGE; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MENSTRUATION; MENSTRUATION DISTURBANCES; PREMENOPAUSE; RISK FACTORS;

EID: 20444424573     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0051     Document Type: Article

References (25)

1. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.
2. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk? Cancer 1985;56:1206-8.
3. Goldfien A. Ovaries. In: Greenspan FS, Gardner DG, editors. Basic and clinical endocrinology. New York: Lange Medical Books; 2001. p. 453-508.
4. Masters JR, Drife JO, Scarisbrick JJ. Cyclic Variation of DNA synthesis in human breast epithelium. J Natl Cancer Inst 1977;58:1263-5.
5. Meyer JS. Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. Hum Pathol 1977;8:67-81.
6. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
7. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
8. Garland M, Hunter DJ, Colditz GA, et al. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol 1998;147:636-43.
9. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 1997;6:49-62.
10. Clavel-Chapelon F. Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 2002;13:831-8.
11. Whelan EA, Sandler DP, Root JL, Smith KR, Weinberg CR. Menstrual cycle patterns and risk of breast cancer. Am J Epidemiol 1994;140:1081-90.
12. Grabrick DM, Vierkant RA, Anderson KE, et al. Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States). Cancer Causes Control 2002;13:333-41.
13. den Tonkelaar I, de Waard F. Regularity and length of menstrual cycles in women aged 41-46 in relation to breast cancer risk: results from the DOM-project. Breast Cancer Res Treat 1996;38:253-8.
14. Wu AH, Ziegler RG, Pike MC, et al. Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer 1996;73:680-6.
15. Yuan JM, Yu MC, Ross RK, Gao YT, Henderson BE. Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 1988;48:1949-53.
16. Parazzini F, La Vecchia C, Negri E, Franceschi S, Tozzi L. Lifelong menstrual patterns and risk of breast cancer. Oncology 1993;1993:222-50.
17. Moseson M, Koenig KL, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993;22:1000-9.
18. Titus-Ernstoff L, Longnecker MP, Newcomb PA, et al. Menstrual factors in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:783-9.
19. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 2000;87:295-300.
20. La Vecchia C, Decarli A, di Pietro S, et al. Menstrual cycle patterns and the risk of breast disease. Eur J Cancer Clin Oncol 1985;21:417-22.
21. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403-7.
22. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991;134:818-24.
23. Anderson KE, Sellers TA, Chen PL, et al. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 1997;79:494-9.
24. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998;51:581-6.
25. Michels KB, Solomon CG, Hu FB, et al. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 2003;26:1752-8.